Methods of treating fibrosing diseases by induction of immune tolerance
View Patent ↗The present invention has demonstrated for the first time that orally administered type I collagen (CI) induced tolerance to CI in patients suffering from systemic sclerosis (SSc) and ameliorated clinical manifestations of the disease. Accordingly, the present invention provides methods of treating a fibrosing disease by oral administration of a tissue protein, for example, collagen, derived from the tissue undergoing fibrosis.
1. A method for treating a scleroderma (SSc) in a patient, comprising orally administering to the patient one or more collagen fragments, said collagen fragments selected from the group consisting of: α1(I) CB1, CB2, CB3, CB4, CB5, CB6, CB7, CB8 and α2(I) CB1, CB2, CB3, CB4 and CB5.
2. The method of claim 1 , wherein said patient has been suffering from said scleroderma (SSc) for at least 3 years.
3. The method of claim 1 , wherein said collagen is derived from human or an animal species other than human.
4. The method of claim 1 , wherein said collagen fragment is orally administered to said patient at about 500 μg/day.
5. The method of claim 4 , wherein the patient is treated for about 12 months.
6. The method of claim 1 , wherein the oral administration of said collagen fragment induces tolerance in said patient.